Association between Helicobacter pylori infection and metabolic syndrome and its components

Ying Liu1,2, Ping Shuai1,2, Wanjing Chen1,2

  • 1Department of Health Management Center & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

PubMed
Abstract

Insights

Helicobacter pylori infection is linked to metabolic syndrome in Chinese males. This study clarifies the association using multiple diagnostic criteria for metabolic syndrome.

Area of Science:

  • Gastroenterology
  • Public Health
  • Epidemiology

Background:

  • The relationship between Helicobacter pylori (H. pylori) infection and metabolic syndrome (MetS) is debated.
  • Previous studies show conflicting results, potentially due to varied MetS diagnostic criteria.

Purpose of the Study:

  • To investigate the association between H. pylori infection and MetS.
  • To analyze this association using five distinct MetS diagnostic criteria.

Main Methods:

  • Utilized physical examination data from 100,708 subjects (2014-2018).
  • Defined MetS using International Diabetes Federation (IDF), ATP III, Joint Statement of International Multi-Societies (JIS), Chinese Diabetes Society (CDS), and CDS DM criteria.
  • Employed multivariate logistic regression to analyze H. pylori infection's link to MetS and its components.

Main Results:

  • MetS prevalence varied by criteria (IDF: 15.8% to JIS: 23.7%).
  • H. pylori-positive males showed higher MetS prevalence and components (dyslipidemia, waist circumference, hypertension, hyperglycemia) than H. pylori-negative males.
  • In females, H. pylori infection was associated with dyslipidemia and increased waist circumference.

Conclusions:

  • H. pylori infection is positively associated with metabolic syndrome in males in China.
  • The study highlights gender-specific associations and the impact of diagnostic criteria on MetS research.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
462
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
213
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
380
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
644
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
468
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
157